Published in Cancer on December 15, 1998
The enigmatic parietal epithelial cell is finally getting noticed: a review. Kidney Int (2009) 1.24
Role of Cks1 overexpression in oral squamous cell carcinomas: cooperation with Skp2 in promoting p27 degradation. Am J Pathol (2004) 1.17
Overexpression of LIM and SH3 Protein 1 leading to accelerated G2/M phase transition contributes to enhanced tumourigenesis in oral cancer. PLoS One (2013) 0.92
Clinico-prognostic value of D-type cyclins and p27 in laryngeal cancer patients: a review. Acta Otorhinolaryngol Ital (2005) 0.81
Immunohistochemical evaluation of oral epithelial dysplasia using cyclin-D1, p27 and p63 expression as predictors of malignant transformation. J Nat Sci Biol Med (2013) 0.80
p27(Kip1) expression as a prognostic marker for squamous cell carcinoma of the head and neck. Oncol Lett (2015) 0.77
Prognostic value of some tumor markers in unresectable stage IV oropharyngeal carcinoma patients treated with concomitant radiochemotherapy. Radiol Oncol (2015) 0.75
Peripheral ameloblastoma: biological profile based on 160 cases from the literature. Oral Oncol (2001) 3.05
Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet (1998) 3.01
Adenocarcinoma arising from a gastric duplication cyst with invasion to the stomach: a case report with literature review. J Clin Pathol (2004) 2.69
Adenomatoid odontogenic tumor: biologic profile based on 499 cases. J Oral Pathol Med (1991) 2.39
Benefit of IVIG for long-standing ataxic sensory neuronopathy with Sjögren's syndrome. IV immunoglobulin. Neurology (2003) 2.37
Frequent amplification of the c-met gene in scirrhous type stomach cancer. Biochem Biophys Res Commun (1992) 2.11
Glue embolization for gastroduodenal ulcer bleeding: contribution to hemodynamics and healing process. Acta Radiol (2013) 1.98
Lingual and buccal mandibular bone depressions: a review based on 583 cases from a world-wide literature survey, including 69 new cases from Japan. Dentomaxillofac Radiol (2002) 1.93
Odontogenic tumors. A demographic study of 759 cases in a Chinese population. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1998) 1.93
Divergent consequences of success and failure in japan and north america: an investigation of self-improving motivations and malleable selves. J Pers Soc Psychol (2001) 1.78
Somatic mutation of the APC gene in gastric cancer: frequent mutations in very well differentiated adenocarcinoma and signet-ring cell carcinoma. Hum Mol Genet (1992) 1.76
Expression of interleukin-8 correlates with vascularity in human gastric carcinomas. Am J Pathol (1998) 1.75
Verruciform xanthoma--biological profile of 282 oral lesions based on a literature survey with nine new cases from Japan. Oral Oncol (2003) 1.71
An optical spectrum of the afterglow of a gamma-ray burst at a redshift of z = 6.295. Nature (2006) 1.70
Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase. Oncogene (2010) 1.68
Expression of epidermal growth factor receptor in human gastric and colonic carcinomas. Cancer Res (1988) 1.67
Frequent replication errors at microsatellite loci in tumors of patients with multiple primary cancers. Cancer Res (1994) 1.61
Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res (1995) 1.60
Molecular mechanism of stomach carcinogenesis. J Cancer Res Clin Oncol (1993) 1.60
A new antimitotic substance, FR182877. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activities. J Antibiot (Tokyo) (2000) 1.57
Periostin is frequently overexpressed and enhances invasion and angiogenesis in oral cancer. Br J Cancer (2006) 1.54
Proliferative activity of calcifying odontogenic cysts as evaluated by proliferating cell nuclear antigen labeling index. Pathol Int (1998) 1.51
Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer. Cancer Res (1990) 1.49
Periostin: novel diagnostic and therapeutic target for cancer. Histol Histopathol (2007) 1.48
Clinicopathological significance of vascular endothelial growth factor (VEGF)-C in human esophageal squamous cell carcinomas. Int J Cancer (2001) 1.44
New procedure for purse-string suture in thoracoscopic esophagectomy with intrathoracic anastomosis. Surg Endosc (2004) 1.41
Frequent loss of heterozygosity on chromosomes 1q, 5q, and 17p in human gastric carcinomas. Cancer Res (1991) 1.41
Clear-cell variant of mucoepidermoid carcinoma: report of a case with immunohistochemical and ultrastructural observations. J Oral Maxillofac Surg (1992) 1.39
A case of ectopic opening of vasa deferentia into müllerian duct cyst. J Pediatr Surg (1992) 1.39
Expression of ERBB2 in human gastric carcinomas: relationship between p185ERBB2 expression and the gene amplification. Cancer Res (1990) 1.38
Polymorphisms of Helicobacter pylori HP0638 reflect geographic origin and correlate with cagA status. J Clin Microbiol (2002) 1.35
Spindle cell squamous carcinoma of the oral region. An immunohistochemical and ultrastructural study on the histogenesis and differential diagnosis with a clinicopathological analysis of six cases. Virchows Arch A Pathol Anat Histopathol (1991) 1.34
Expression of CD44 abnormal transcripts in human gastric carcinomas. Cancer Lett (1994) 1.34
Vascular endothelial growth factor-C expression predicts lymph node metastasis of human gastric carcinomas invading the submucosa. Eur J Cancer (2002) 1.31
Desmoplastic ameloblastoma (including "hybrid" lesion of ameloblastoma). Biological profile based on 100 cases from the literature and own files. Oral Oncol (2001) 1.30
Non-calcifying Pindborg tumor with Langerhans cells. J Oral Pathol Med (1993) 1.30
High expression of S-phase kinase-interacting protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas. Cancer Res (2001) 1.27
Microsatellite instability in precancerous lesions and adenocarcinomas of the stomach. Cancer (1996) 1.26
Down-regulation of the claudin-18 gene, identified through serial analysis of gene expression data analysis, in gastric cancer with an intestinal phenotype. J Pathol (2006) 1.26
Transfection of interleukin-8 increases angiogenesis and tumorigenesis of human gastric carcinoma cells in nude mice. Br J Cancer (1999) 1.26
Significance of vessel count and vascular endothelial growth factor in human esophageal carcinomas. Clin Cancer Res (1998) 1.26
Reg IV is a serum biomarker for gastric cancer patients and predicts response to 5-fluorouracil-based chemotherapy. Oncogene (2007) 1.26
Myonuclear number and myosin heavy chain expression in rat soleus single muscle fibers after spaceflight. J Appl Physiol (1985) (1996) 1.24
Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions. Clin Cancer Res (1995) 1.24
The FGFR1 inhibitor PD173074 induces mesenchymal-epithelial transition through the transcription factor AP-1. Br J Cancer (2013) 1.23
Morphological changes in human gastric tumours after eradication therapy of Helicobacter pylori in a short-term follow-up. Aliment Pharmacol Ther (2005) 1.23
Odontogenic ghost cell carcinoma: report of four new cases and review of the literature. J Oral Pathol Med (1999) 1.21
Genetic and epigenetic alterations in multistep carcinogenesis of the stomach. J Gastroenterol (2000) 1.20
Expression of the E2F family in human gastrointestinal carcinomas. Int J Cancer (1999) 1.20
Reduced expression of cyclin-dependent kinase inhibitor p27Kip1 is associated with advanced stage and invasiveness of gastric carcinomas. Jpn J Cancer Res (1997) 1.18
Molecular diagnosis of gastric cancer: present and future. Gastric Cancer (2001) 1.18
Relative expression of E-cadherin and type IV collagenase genes predicts disease outcome in patients with resectable pancreatic carcinoma. Clin Cancer Res (1999) 1.18
Abnormal retention of intron 9 in CD44 gene transcripts in human gastrointestinal tumors. Cancer Res (1995) 1.18
Isolation of an amplified DNA sequence in stomach cancer. Jpn J Cancer Res (1990) 1.18
Expression of epidermal growth factor, transforming growth factor-alpha and their receptor genes in human gastric carcinomas; implication for autocrine growth. Jpn J Cancer Res (1990) 1.18
Co-expression of osteopontin and CD44v9 in gastric cancer. Int J Cancer (1998) 1.18
Expression and up-regulation of retinoic acid receptor-beta is associated with retinoid sensitivity and colony formation in esophageal cancer cell lines. Cancer Res (1999) 1.18
Regulation of disease-progression genes in human gastric carcinoma cells by interleukin 8. Clin Cancer Res (2000) 1.17
Expression of TGF-beta and procollagen type I and type III in human gastric carcinomas. Int J Cancer (1989) 1.17
Differential immunohistochemical detection of amphiregulin and cripto in human normal colon and colorectal tumors. Cancer Res (1992) 1.17
Expression of bone associated markers by tooth root lining cells, in situ and in vitro. Bone (1997) 1.15
Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine. Cancer (1997) 1.15
Interaction between epidermal growth factor and its receptor in progression of human gastric carcinoma. Int J Cancer (1988) 1.14
Mandibular adenomatoid odontogenic tumor with unusual clinicopathologic features. J Oral Maxillofac Surg (1992) 1.14
Endocrine cell carcinoma (carcinoid) of the gallbladder. Am J Surg Pathol (1989) 1.13
High incidence of coamplification of hst-1 and int-2 genes in human esophageal carcinomas. Cancer Res (1989) 1.13
Survivin, a potential early predictor of tumor progression in the oral mucosa. J Dent Res (2003) 1.13
The inflammatory paradental cyst: a critical review of 342 cases from a literature survey, including 17 new cases from the author's files. J Oral Pathol Med (2004) 1.12
Frequent p53 gene mutations in serrated adenomas of the colorectum. J Pathol (1998) 1.10
Cementum: a phosphate-sensitive tissue. J Dent Res (2002) 1.10